Presentations.AI, a Beautiful.ai Alternative, Launches Unlimited-Seat Team Plan to Challenge Per-User Pricing, Adding Automatic Brand Sync and Document-to-Presentation Conversion Revolution Medicines Announces Pricing of Upsized $260.9 Million Public Offering of Common Stock
REDWOOD CITY, Calif., Feb. 03, 2021 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD) today…
Sana Announces Upsized Pricing of Initial Public Offering
SEATTLE, Feb. 03, 2021 (GLOBE NEWSWIRE) — Sana Biotechnology, Inc. (Sana) (Nasdaq: SANA), a company…
Novavax and Government of Switzerland Announce Agreement in Principle to Supply COVID-19 Vaccine
Switzerland to purchase six million doses of the Novavax vaccine candidate, NVX-CoV2373 GAITHERSBURG, Md., Feb….
Sensei Biotherapeutics Announces Pricing of Upsized Initial Public Offering
BOSTON and ROCKVILLE, Md., Feb. 03, 2021 (GLOBE NEWSWIRE) — Sensei Biotherapeutics, Inc., a clinical-stage…
Landos Biopharma Announces Pricing of Initial Public Offering
BLACKSBURG, Va., Feb. 03, 2021 (GLOBE NEWSWIRE) — Landos Biopharma, a clinical-stage biopharmaceutical company focused…
Iterum Therapeutics plc Announces $10 Million Bought Deal Public Offering of Ordinary Shares
DUBLIN, Ireland and CHICAGO, Feb. 03, 2021 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM)…
Psyence Group Presenting at Canaccord Genuity Conference “New Paradigms & Treatment Approaches in Mental Health”
TORONTO, Feb. 03, 2021 (GLOBE NEWSWIRE) — Psyence Group Inc. (CSE: PSYG) (“Psyence” or the…
Rubius Therapeutics to Participate in Guggenheim Healthcare Talks | 2021 Oncology Days
CAMBRIDGE, Mass., Feb. 03, 2021 (GLOBE NEWSWIRE) — Rubius Therapeutics, Inc. (Nasdaq: RUBY), a clinical-stage…
ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Feb. 03, 2021 (GLOBE NEWSWIRE) — ORIC Pharmaceuticals,…
Translate Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
LEXINGTON, Mass., Feb. 03, 2021 (GLOBE NEWSWIRE) — Translate Bio (Nasdaq: TBIO), a clinical-stage messenger…
Codexis Appoints Dr. Esther Martinborough to its Board of Directors
REDWOOD CITY, Calif., Feb. 03, 2021 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq:CDXS), a leading enzyme…
Rhythm Pharmaceuticals, Inc. Announces Proposed Public Offering
BOSTON, Feb. 03, 2021 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a biopharmaceutical company…
Assertio Announces $5.0 Million Insurance Settlement and General Corporate Updates
LAKE FOREST, Ill., Feb. 03, 2021 (GLOBE NEWSWIRE) — Assertio Holdings, Inc. (“Assertio” or the…
Yield10 Bioscience Announces Closing of $12.7 Million Public Offering
WOBURN, Mass., Feb. 03, 2021 (GLOBE NEWSWIRE) — Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural…
Medexus Announces Upsize to Previously Announced Bought Deal Public Offering
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED…
Red Light Holland Announces Increase in Bought Deal Equity Financing to $10 Million
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED…
Skye Bioscience to Participate in Investment Conferences in February
San Diego, Calif., Feb. 03, 2021 (GLOBE NEWSWIRE) — Skye Bioscience, Inc. (OTCQB: SKYE) (“SKYE”…
Alliance for Regenerative Medicine Responds to EU Beating Cancer Plan
Alliance for Regenerative Medicine Responds to EU Beating Cancer Plan ATMPs are uniquely positioned to…
Generex Biotechnology Announces Call-in Details and Agenda for Shareholder Conference Call on Friday February 5, 2021 at 9:00 AM
The access information for the investor conference call is as follows: Domestic US/Canada – 1-(866)…
Marrone Bio Innovations Issues Shareholder Letter
DAVIS, Calif., Feb. 03, 2021 (GLOBE NEWSWIRE) — Marrone Bio Innovations, Inc. (NASDAQ: MBII) (“Marrone…